Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
A randomized clinical trial designed and intended to evaluate the efficacy of Dexamethasone and Methylprednisolone as a treatment for severe Acute Respiratory Distress Syndrome (ARDS) caused by coronavirus disease 19 (COVID-19). Our aim is to find the best option for the treatment and management of ARDS in COVID-19 patients.
Epistemonikos ID: eb0142bb23ac82405f9172721cfcbf931027f79c
First added on: Aug 06, 2020